ALDH1 is a prognostic factor for patients treated with neoadjuvant chemoradiotherapy and radical resection for stage III rectal cancer.

@article{Oh2015ALDH1IA,
  title={ALDH1 is a prognostic factor for patients treated with neoadjuvant chemoradiotherapy and radical resection for stage III rectal cancer.},
  author={Seung Yeop Oh and Se Hwa Sohn and Hyunee Yim and Dakeun Lee and Kwang Wook Suh and Young-Bae Kim},
  journal={Journal of surgical oncology},
  year={2015},
  volume={111 2},
  pages={
          243-7
        }
}
BACKGROUND AND OBJECTIVES The factors relating to changes within a tumor after preoperative chemoradiotherapy associated with rectal cancer prognosis remain to be determined. The aim of this study was to investigate the expression of CD133 and ALDH1 and to analyze the predictive and prognostic roles in patients with rectal cancer after chemoradiotherapy. METHODS We analyzed the expression levels of ALDH1 and CD133 in patients with middle and lower rectal cancers who underwent preoperative… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 4 times. VIEW TWEETS

Similar Papers

Loading similar papers…